保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Recurso digital |
| 言語: | 英語 |
| 出版事項: |
Zenodo
2009
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.5281/zenodo.6405776 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
目次:
- <p>This is Feedback on the following Cochrane review: Kaur B, Rowe BH, Arnold E. Vitamin C supplementation for asthma. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000993. <a href="https://www.ncbi.nlm.nih.gov/pubmed/19160185">pubmed/19160185</a> doi: <a href="https://doi.org/10.1002/14651858.CD000993.pub3">10.1002/14651858.CD000993.pub3</a></p> <p>This Feedback was published within the Cochrane review, see: <a href="https://helda.helsinki.fi/handle/10138/296440">https://helda.helsinki.fi/handle/10138/296440</a></p> <p>The first version of the Cochrane review was published in 2001: Kaur B, Rowe BH, Ram FS. Vitamin C supplementation for asthma.<br>Cochrane Database Syst Rev. 2001;(4):CD000993. <a href="https://www.ncbi.nlm.nih.gov/pubmed/11687089">pubmed/11687089</a><br>The second version of the Cochrane review was published in 2004: Ram FS, Rowe BH, Kaur B. Vitamin C supplementation for asthma.Cochrane Database Syst Rev. 2004;(3):CD000993. <a href="https://www.ncbi.nlm.nih.gov/pubmed/15266435">pubmed/15266435</a></p> <p>This Feedback below points out errors in Analyses 1.1, 1.2, 1.3 and 1.5 of the Cochrane review (2009 version). However, all these analyses were identical already in the first version (2001) of the Cochrane review. Thus, because of the errors described in this feedback, the Cochrane review “Vitamin C supplementation for asthma” had been misleading readers for a decade.</p> <p>In addition to the problems described in this Feedback (2009) below, there are a number of additional problems in the Cochrane review “vitamin C supplementation for asthma” (2009), which are described in: <a href="https://helda.helsinki.fi/handle/10138/40816">https://helda.helsinki.fi/handle/10138/40816</a> with a copy at <a href="../doi/10.5281/zenodo.6405803">Zenodo</a>.</p> <p>Correction of the errors was a confusing process and briefly described in: Hemilä H. Cochrane has not consistently followed the COPE guidelines. Eur J Clin Invest. 2020;50(4):e13216. <a href="../doi/10.5281/zenodo.6405803">https://doi.org/10.1111/eci.13216</a> <a href="https://hdl.handle.net/10138/326823">https://hdl.handle.net/10138/326823 </a> </p> <p> </p>